To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04704323
Title CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catapult Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Duke University RECRUITING Durham North Carolina 27705 United States Details
Hospital Universitario de La Princesa NOT_YET_RECRUITING Madrid 28006 Spain Details
Hospital Universitario Marqués de Valdecilla NOT_YET_RECRUITING Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field